» Articles » PMID: 8435390

Relationship of Regression Pattern to Recurrence in Retinoblastoma

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1993 Jan 1
PMID 8435390
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A retrospective analysis has been conducted of regression patterns following treatment of retinoblastoma by external beam irradiation. There were 180 tumours in 105 eyes of 83 patients. Type I regression was found to be the commonest pattern and occurred in 50% of cases. Initial tumour size was found to be the only statistically significant determinant of regression pattern (p < 0.01). Thirteen tumours (7%) recurred within a median interval to recurrence of 12 months. All recurrences occurred within 40 months of completion of treatment and none occurred after age 4 years. No tumour less than 6 mm in diameter recurred. Although 10 out of 13 recurrences were of Type I, Cox model regression analysis showed initial tumour size to be the only independent predictor of recurrence (p < 0.01).

Citing Articles

Primary Subretinal Seeding in Retinoblastoma: Clinical Presentation and Treatment Outcomes.

Bakal K, Raval V, Gattu S, Palkonda V, Kaliki S Ocul Oncol Pathol. 2024; 9(1-2):32-39.

PMID: 38376084 PMC: 10821785. DOI: 10.1159/000530497.


Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes.

Chandra K, Raval V, Reddy P V, Kaliki S J Vitreoretin Dis. 2023; 6(5):367-373.

PMID: 37006899 PMC: 9954921. DOI: 10.1177/24741264221107757.


A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.

Berry J, Kogachi K, Murphree A, Jubran R, Kim J Int Ophthalmol Clin. 2019; 59(2):65-75.

PMID: 30908280 PMC: 6676476. DOI: 10.1097/IIO.0000000000000269.


Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.

Chawla B, Jain A, Seth R, Azad R, Mohan V, Pushker N Indian J Ophthalmol. 2016; 64(7):524-9.

PMID: 27609166 PMC: 5026079. DOI: 10.4103/0301-4738.190143.


Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.

Kim J, Kim J, Kim S, Park K, Shin H, Ahn H Korean J Ophthalmol. 2010; 24(6):347-52.

PMID: 21165233 PMC: 2992562. DOI: 10.3341/kjo.2010.24.6.347.


References
1.
Sanders B, Draper G, Kingston J . Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988; 72(8):576-83. PMC: 1041531. DOI: 10.1136/bjo.72.8.576. View

2.
Shields J, Shields C, Donoso L, Lieb W . Changing concepts in the management of retinoblastoma. Ophthalmic Surg. 1990; 21(1):72-6. View

3.
REESE A, Ellsworth R . The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963; 67:164-72. View

4.
Stallard H . The conservative treatment of retinoblastoma. Trans Ophthalmol Soc U K (1962). 1962; 82:473-534. View

5.
DUNPHY E . THE STORY OF RETINOBLASTOMA. THE XX EDWARD JACKSON MEMORIAL LECTURE. Am J Ophthalmol. 1964; 58:539-52. View